Defibrillators Implantable
Mostrando 1-12 de 37 artigos, teses e dissertações.
-
1. Comparison of Anxiety and Depression Symptoms in Individuals According to their Sex, Type of Cardiac Device, and Diagnosis of Chagas Disease
ABSTRACT Introduction: Implantable cardiac pacemakers or cardioverter defibrillators are alternatives for the treatment of arrhythmias, however, their use has caused changes in the emotional state of patients. The objective of this study was to compare the measures of anxiety and depression symptoms in individuals according to their sex, type of cardiac dev
Brazilian Journal of Cardiovascular Surgery. Publicado em: 2022
-
2. ICD indication in hypertrophic cardiomyopathy: which algorithm to use?
SUMMARY OBJECTIVE: This study aimed to evaluate the agreement in the indication of implantable cardioverter-defibrillators in patients with Hypertrophic cardiomyopathy, as per the 2014 European Society of Cardiology and 2020 American Heart Association recommendations, and evaluate fragmented QRS as a predictor of cardiovascular outcome. METHODS: Retrospect
Revista da Associação Médica Brasileira. Publicado em: 2022
-
3. Update on Sports Participation for Athletes with Implantable Cardioverter Defibrillators
Abstract Prior statements have recommended restriction from competitive sports participation for all athletes with ICDs. Recent data, however, suggests that many athletes can participate in sports without adverse events. In the ICD Sports Registry, 440 athletes, aged 8-60 years, 77 of which were high-level interscholastic athletes, who had continued to pract
Int. J. Cardiovasc. Sci.. Publicado em: 12/08/2019
-
4. Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up
Resumo Fundamento: O uso de dispositivos cardíacos eletrônicos implantáveis (DCEI) como o cardiodesfibrilador (CDI) e terapia de ressincronização cardíaca (TRC) - é cada vez maior. O número de eletrodos de estimulação e desfibrilação varia de acordo com o dispositivo. A colocação do eletrodo no ventrículo esquerdo aumenta o tempo cirúrgico p
Arq. Bras. Cardiol.. Publicado em: 21/02/2019
-
5. Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis
Abstract Objective: Implantable cardioverter-defibrillator has become the first-line therapy for prevention of sudden cardiac death. Controversial results still exist regarding the effectiveness of implantable cardioverter-defibrillator (ICD) in non-ischemic heart failure. Methods: The PubMed, Embase, and Cochrane Central databases were searched for random
Braz. J. Cardiovasc. Surg.. Publicado em: 2017-10
-
6. Ventricular arrhythmias in Chagas disease
Sudden death is one of the most characteristic phenomena of Chagas disease, and approximately one-third of infected patients develop life-threatening heart disease, including malignant ventricular arrhythmias. Fibrotic lesions secondary to chronic cardiomyopathy produce arrhythmogenic substrates that lead to the appearance and maintenance of ventricular arrh
Rev. Soc. Bras. Med. Trop.. Publicado em: 13/02/2015
-
7. Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review
This article is a systematic review of the available literature on the benefits that cognitive behavioral therapy (CBT) offers patients with implanted cardioverter defibrillators (ICDs) and confirms its effectiveness. After receiving the device, some patients fear that it will malfunction, or they remain in a constant state of tension due to sudden electrica
Braz J Med Biol Res. Publicado em: 18/03/2014
-
8. Avaliação da fibrose miocárdica pela ressonância magnética e tomografia computadorizada com múltiplos detectores na cardiomiopatia hipertrófica / Myocardial fibrosis evaluation by magnetic resonance and multidetector computed tomography in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder leading cause of sudden death in young people with extremely variable presentation, from asymptomatic to sudden death as first symptom, leads to challenging risk stratification. Recently, both cardiovascular magnetic resonance (CMR) and multidetector computed tomography (MDCT) were able to asses
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 09/08/2011
-
9. Preditores de mortalidade geral em pacientes portadores de cardiopatia chagásica crônica tratados com cardioversor-desfibrilador implantável.
In most Chagas disease patients, sudden cardiac death is caused by Sustained Ventricular Tachycardia or Ventricular Fibrillation. Implantable Cardioverter Defibrillators have sporadically been used as a treatment for such arrhythmias in Chagas disease patients. This study aimed at determining predictors of all-cause mortality for Chagas disease patients rece
Publicado em: 2006
-
10. Acompanhamento de pacientes chagásicos portadores de arritmia ventricular submetidos a implante de cardioversor-desfibrilador.
The natural history of Chagas disease has two important distinct phases: acute and chronic. The chronic phase usually occurs thirty to forty years after the initial infestation. Cardiac arrhythmia and electric conduction disturbances are manifestations of chronic phase of Chagas disease. Life threatening ventricular arrhythmias present on this phase, may be
Publicado em: 2004
-
11. "Cardiomiopatia hipertrófica: importância dos eventos arrítmicos em pacientes com risco de morte súbita" / Hypertrophic cardiomyopathy: sudden cardiac death in high risk patients and the role of arrhythmias
Vinte e seis pacientes com cardiomiopatia hipertrófica e fatores de risco de morte súbita, foram submetidos a implante de cardioversor-desfibrilador implantável de dupla-câmara, com seguimento médio de 19 meses. Observou-se quatro choques em arritmias letais, 4 pacientes apresentaram TVNS e 5 taquiarritmias supraventriculares. Ocorreu um óbito.Conclus�
Publicado em: 2004
-
12. Estudo dos episodios de taquicardia detectados por desfibrilador automatico implantavel : implicações diagnosticas e terapeuticas
INTRODUCTION: The development of automatic implantable defibrillators has been fast in the last few years. A device initially conceived to treat patients with serious docummented arrhythmias is now more and more used to primary prevention of sudden cardiac death. There was a huge evolution in the size and capacity ofthe devices, but programming is still a ma
Publicado em: 2002